Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Ital J Pediatr ; 48(1): 21, 2022 Feb 03.
Article in English | MEDLINE | ID: mdl-35115016

ABSTRACT

OBJECTIVE: To evaluate the role and the advantages of nasopharyngeal swabs in the detection of Influenza A and B viruses and Respiratory syncytial virus through a rapid test based upon a nucleic acid amplification reaction in order to avoid improper antibiotics use. DESIGN: Case-control retrospective study. SETTING: Emergency Room of "Sandro Pertini" General Hospital, Rome, Italy. PARTICIPANTS: Children (< 14 years old) who consecutively arrived in the Emergency Department (ED) for respiratory tract infections, without obvious signs of bacterial respiratory tract infections and other comorbidities, in the maximal seasonal incidence period of November-to-March of every year between 2016 and 2020. METHODS: Medical records of children included in the study were retrospectively examined. Children were subdivided according to the following intervals: 2016-2017 and 2017-2018 (Group 1), 2018-2019 and 2019-2020 (Group 2). Children in Group 2 undertook a nasopharyngeal swab, while those in Group 1 did not undergo any specific diagnostic test. PRIMARY OUTCOME: Avoidance of improper antibiotics administration. RESULTS: A total of 386 children were included in the study: 174 in Group 1, 212 in Group 2. The Odd Ratio (OR) of prescribing an antibiotic in the groups of children not being swabbed compared to those of children undertaking a swab was 9.21 (CI95% 5.6-15.2, p < 0.001). The overall percentage of hospitalizations, both in the short observation unit or in the pediatric unit, did not differ between the two groups. CONCLUSIONS: Nasopharyngeal swabs for the detection of Influenza A and B viruses and Respiratory syncytial virus proved to be a useful means to a correct and timely diagnosis and allowed for a significant reduction in the prescription of antibiotic therapy. TRIAL REGISTRATION: Retrospectively registered.


Subject(s)
Influenza, Human , Respiratory Syncytial Virus Infections , Respiratory Syncytial Virus, Human , Respiratory Tract Infections , Adolescent , Child , Humans , Infant , Influenza, Human/diagnosis , Influenza, Human/epidemiology , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/epidemiology , Retrospective Studies
2.
J Asthma ; 48(4): 419-26, 2011 May.
Article in English | MEDLINE | ID: mdl-21410425

ABSTRACT

BACKGROUND: To investigate whether an active partnership between schools, parents, and pediatricians can improve the management of asthma and quality of life of children with asthma. METHODS: A comprehensive asthma program (Happy Air®), based on a strong family-physician-school relationship, was carried out over a period of 3 years in six primary schools (2765 children). This program provides educational intervention to families, school staff, and students, as well as the administration of written questionnaires to identify children with asthma, asthma diagnosis and management, and, last but not least, extracurricular activities to improve respiratory and psychological conditions. Quality of life of children and parents, at the beginning and end of the program, was assessed using PedsQL™ 4.0 (Pediatric Quality of Life Inventory) measurement model. RESULT: Asthma was diagnosed in 135 children, of which 37 (27%) were diagnosed de novo. In all children, both single item and total clinical asthma scores showed a significant increase (p < .001) at the end of the Happy Air® program. The average scores of both the total PedsQL™ 4.0 and the four Scales were significantly increased (p < .001). CONCLUSION: Happy Air® is a model for a strategy of education- and school-based intervention for children with asthma and their families. This multi-action program for diagnosis, clinical follow-up, education, self-management, and quality-of-life control aims to minimize the socioeconomic burden of asthma disease.


Subject(s)
Asthma/diagnosis , Asthma/prevention & control , Health Education , School Health Services/organization & administration , Schools , Students , Asthma/physiopathology , Asthma/psychology , Child , Family , Health Status , Humans , Quality of Life , Severity of Illness Index , Spirometry
4.
Clin Immunol ; 128(3): 322-8, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18708023

ABSTRACT

The identification of a Btk mutation in a male patient with <2% CD19(+) B cells warrants making the diagnosis of X-linked Agammaglobulinemia (XLA). Herein we report the case of a 31 year-old male with a gradual decline of peripheral B lymphocytes and low IgA and IgM but normal IgG levels. His clinical history revealed recurrent respiratory and skin infections, sclerosing cholangitis and chronic obstructive pancreatitis. Molecular studies revealed a novel aminoacidic substitution in Btk protein (T316A). His mother, maternal aunts and a maternal female cousin were heterozygotes for the same Btk mutation and were variably affected with pulmonary emphysema. This is a puzzling case where the patient's clinical history and laboratory findings divorce molecular genetics. Either this case confirms the variable expressivity of XLA disease or the T316A change in Btk SH2 domain is a novel non-pathogenic mutation and another unknown gene alteration is responsible for the disease.


Subject(s)
Agammaglobulinemia/diagnosis , Agammaglobulinemia/genetics , B-Lymphocytes , Genetic Diseases, X-Linked/diagnosis , Lymphocyte Subsets/immunology , Mutation, Missense , Protein-Tyrosine Kinases/genetics , Adult , Agammaglobulinaemia Tyrosine Kinase , Agammaglobulinemia/immunology , Amino Acid Substitution , B-Lymphocytes/immunology , Female , Genetic Diseases, X-Linked/immunology , Genetic Diseases, X-Linked/metabolism , Humans , Lymphocyte Count , Lymphocyte Subsets/metabolism , Male , Pedigree , Protein-Tyrosine Kinases/chemistry , Protein-Tyrosine Kinases/metabolism
5.
Acta Paediatr ; 96(3): 469-71, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17407484

ABSTRACT

UNLABELLED: Temporary henna tattoos have become increasingly popular as a safe alternative to permanent tattoos among American and European children and teenagers during the summer holidays. Currently, temporary henna tattoos contain not only henna, but also other additives such as para-phemylenediamine (PPD), which is considered to be the chemical agent that most frequently causes skin reactions associated with the use of commercial black henna. In this report, we describe an 11-year-old boy who applied a temporary black henna tattoo on his right arm during the summer holidays in Greece and developed a severe contact dermatitis at the tattoo site with residual hypopigmentation. He had no previous history of contact dermatitis, however he did suffer from seasonal allergic rhinitis and atopic dermatitis. Patch testing revealed a strong reaction to PPD, a substance commonly contained in temporary henna tattoo preparations. CONCLUSION: Henna tattoos are an increasing problem worldwide since they carry an increased risk of severe skin reactions; therefore we suggest that the use of temporary henna tattoos in children be discouraged.


Subject(s)
Coloring Agents/adverse effects , Dermatitis, Allergic Contact/etiology , Naphthoquinones/adverse effects , Tattooing/adverse effects , Child , Dermatitis, Allergic Contact/epidemiology , Dermatitis, Allergic Contact/immunology , Dermatitis, Atopic/epidemiology , Humans , Male , Naphthoquinones/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...